Trial Profile
Interleukin 2 and zolendronic acid as maintaining treatment in multiple myeloma patients after autologous bone marrow transplant Mantenimento Immunologico con interleuchina-2 e acido zoledronico in pazienti con Mieloma Multiplo sottoposti a trapianto Autologo di cellule staminali
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2014
Price :
$35
*
At a glance
- Drugs Aldesleukin (Primary) ; Zoledronic acid (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms MIMMA
- 04 Jul 2014 New trial record